100 Abbott Park Road
Chicago,  IL  60064

United States
  • Booth: PSC

Abbott is a global leader in in vitro diagnostics with one of the broadest portfolio of businesses spanning nearly every segment – point of care, immunoassay, clinical chemistry, hematology, blood screening, molecular, and informatics. Abbott’s life-changing tests and diagnostic tools provide accurate, timely information to better manage health. We’re empowering smarter medical and economic decision making to help transform the way people manage their health at all stages of life.


  • i-STAT TBI Plasma Test
    Biomarker assay to aid in the evaluation of patients with suspected mild traumatic brain injury (mTBI)....

  • The i-STAT TBI Plasma test, in conjunction with other clinical information, assists in determining the need for a CT in adults. It measures the levels of 2 complementary, brain-specific biomarkers, glial fibrillary acidic protein (GFAP) and ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1), in a single, multiplex test. Results are available in approximately 15 minutes after preparing a plasma sample. With a negative predictive value (NPV) of 99.3% and a clinical sensitivity of 95.8%, the i-STAT TBI Plasma Test can decrease unnecessary CT by up to 40%.1,2 The TBI test can provide confidence by aiding decisions for the safe discharge of patients without performing CT. Reducing unnecessary CT may have positive implications for ED workflow, resource utilization, and patient satisfaction.

    1. i-STAT TBI Plasma Cartridge. Instructions for use. Abbott Point of Care Inc. Abbott Park, IL; 2021. 2. Data on file. Abbott Point of Care Inc

    Abbott Point of Care

    For in vitro diagnostic use only. i-STAT and Alinity are trademarks of Abbott. For intended use and complete product information, visit